Publish: 03 Jul 2021, 08:49 am
US Ambassador Earl R. Miller greeted the arrival of the United States’ gift from the American people of 2.5 million doses of Moderna’s COVID-19 vaccine to Bangladesh, delivered via COVAX.
Aircraft delivered the shipment of vaccines from the US on Friday night and Saturday morning through the COVAX Advance Market Commitment, a global initiative to support equitable access to COVID-19 vaccines.
Foreign Minister AK Abdul Momen, Health Minister Zahid Maleque MP, Foreign Secretary Masud Bin Momen and Health Secretary Lokman Hossain Mian also welcomed the arrival with Ambassador Miller of the first doses of the US donation to Bangladesh in the late hours of July 2.
The United States embassy in a statement on Saturday said the country is committed to leading the global response to the COVID-19 pandemic.
President Biden reaffirmed this commitment by announcing the US will donate 80 million doses of vaccine to support global needs.
The US is working with its G7 partners, the EU, COVAX, and others in a multilateral effort focused on saving lives, ending the pandemic, and supporting the global economic recovery.
The United States made an initial $2 billion donation of a total planned $4 billion to Gavi, the Vaccine Alliance to support the COVAX Advance Market Commitment, which accelerates access to COVID-19 vaccines, making the United States the largest donor for equitable global COVID-19 vaccine access.
COVAX (COVID-19 Vaccines Global Access) is a worldwide initiative to facilitate global access to COVID-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations, and the World Health Organization.
“This gift from the American people of 2.5 million vaccine doses is just the latest demonstration of US commitment to COVID-19 assistance to Bangladesh. The United States is the largest donor to Bangladesh’s pandemic response efforts. And to be clear: these vaccine donations are only the beginning. We will continue to donate surplus supply, as it becomes available,” said Ambassador Miller.
“We are doing this with the singular objective of saving lives, and because it is the right thing to do.”
The US contributions to COVAX, through the U.S. Agency for International Development (USAID), will support the purchase and delivery of safe and effective COVID-19 vaccines for the world’s most vulnerable and at-risk populations in 92 low- and middle-income countries.